AB0164 ARE PATIENTS WITH RA IN REMISSION IN FINLAND DURING THE COVID TIMES? RESULTS FROM THE FINNISH QUALITY REGISTER

Background Worries have been expressed, concerning the care of chronic diseases during Covid times (1). Objectives To study current status patients with RA in Finnish quality register database. Methods Patients who receive for were identified Clinical and demographic data from last visits 2020-21 collected, including swollen (SJC46) tender joint counts (TJC46), doctor assessment disease activity (Dr global), laboratory tests inflammatory serology markers, patient reported outcomes (PROs), DAS28. Regression models applied to compare measures clinical between health regions, adjusted gender, age, ACPA status, duration. Results A total 14163 (72% female, mean (SD) age 62 (14) years, median (IQR) duration 8.5 (2.6, 20) 84% positive) identified. For entire population, SJC46 was 0 (0, 1), TJC46 2), ESR 8 (5, 18), CRP 3 (1, 6), dr global 19). Among PROs, HAQ 0.5 pain 26 (10, 51), fatigue 28 (8, 54) 29 (11, 51). Between statistically significant differences found all variables due a large sample size. The DAS28 2.3 (0.9) group 69 % had DAS28<2.6. ranged 2 2.7 among regions (Figure 1) (p<0.001). Majority taking csDMARDs only. Figure 1. Rheumatoid arthritis 2020-21: DAS28-values 19 Finland. Conclusion provides comprehensive real-world on RA. majority can be considered being remission even times. References [1] Glintborg et al. Rheumatology (Oxford) 2021 Oct 9;60(SI):SI3-SI12 Acknowledgements I would like thank Society Psoriasis Association their grants. Disclosure Interests None declared